Ignite Creation Date:
2025-12-24 @ 3:59 PM
Ignite Modification Date:
2026-01-26 @ 8:07 PM
Study NCT ID:
NCT02025192
Status:
COMPLETED
Last Update Posted:
2020-06-04
First Post:
2013-12-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Tucatinib (ONT-380) Combined With Capecitabine and/or Trastuzumab in Patients With HER2+ Metastatic Breast Cancer
Sponsor:
Organization: